Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DRTS

Alpha Tau Medical (DRTS)

Alpha Tau Medical Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRTS
DateTimeSourceHeadlineSymbolCompany
3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
05/13/20248:30AMGlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSAlpha Tau Medical Ltd
05/06/20248:30AMGlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSAlpha Tau Medical Ltd
05/01/20248:30AMGlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSAlpha Tau Medical Ltd
03/25/20248:50AMGlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSAlpha Tau Medical Ltd
03/07/20244:13PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRTSAlpha Tau Medical Ltd
03/07/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
03/07/20244:01PMGlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
02/26/20248:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
02/26/20248:30AMGlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
12/20/20239:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
12/20/20239:15AMGlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
12/18/202311:09AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
11/29/20238:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
11/29/20238:30AMGlobeNewswire Inc.Alpha Tau to Participate in Sidoti Small-Cap ConferenceNASDAQ:DRTSAlpha Tau Medical Ltd
11/28/20238:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
11/28/20238:30AMGlobeNewswire Inc.Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNASDAQ:DRTSAlpha Tau Medical Ltd
11/21/20236:18AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DRTSAlpha Tau Medical Ltd
11/20/20238:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
11/20/20238:30AMGlobeNewswire Inc.Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNASDAQ:DRTSAlpha Tau Medical Ltd
11/16/20234:32PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
11/16/20234:30PMGlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSAlpha Tau Medical Ltd
11/01/20235:18PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
11/01/20238:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
10/30/20238:31AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
10/30/20238:30AMGlobeNewswire Inc.Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityNASDAQ:DRTSAlpha Tau Medical Ltd
10/24/20239:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
10/24/20239:00AMGlobeNewswire Inc.Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardNASDAQ:DRTSAlpha Tau Medical Ltd
09/27/20237:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSAlpha Tau Medical Ltd
09/25/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRTSAlpha Tau Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:DRTS